Stock Earnings
An Analysis of Taysha Gene Therapies Inc (TSHA)’s Potential Price Growth
Taysha Gene Therapies Inc’s filing revealed that its Officer Rumana Haque-Ahmed acquired Company’s shares for reported $30479.0 on Sep 22
Menu
Taysha Gene Therapies Inc’s filing revealed that its Officer Rumana Haque-Ahmed acquired Company’s shares for reported $30479.0 on Sep 22
In a filing, Taysha Gene Therapies Inc revealed its President and Head of R&D Nagendran Sukumar unloaded Company’s shares for
In a filing, Taysha Gene Therapies Inc revealed its President and Head of R&D Nagendran Sukumar unloaded Company’s shares for
In a filing, Taysha Gene Therapies Inc revealed its President and Head of R&D Nagendran Sukumar unloaded Company’s shares for
Taysha Gene Therapies Inc’s filing revealed that its President and Head of R&D Nagendran Sukumar unloaded Company’s shares for reported
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Taysha Gene Therapies Inc’s recently made public that its 10% Owner Manning Paul B acquired Company’s shares for reported $2.06
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Taysha Gene Therapies Inc’s recently made public that its 10% Owner Manning Paul B acquired Company’s shares for reported $2.06
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its